James Fleming to Risk Assessment
This is a "connection" page, showing publications James Fleming has written about Risk Assessment.
Connection Strength
0.093
-
A Critical Analysis of the Specific Pharmacist Interventions and Risk Assessments During the 12-Month TRANSAFE Rx Randomized Controlled Trial. Ann Pharmacother. 2022 06; 56(6):685-690.
Score: 0.030
-
Liver Transplantation in the Obese Cirrhotic Patient. Transplantation. 2017 10; 101(10):2288-2296.
Score: 0.023
-
Morbid obesity and functional status as predictors of surgical complication after renal transplantation. Am J Surg. 2018 Apr; 215(4):663-668.
Score: 0.022
-
25-hydroxyvitamin D deficiency and opportunistic viral infections after kidney transplant. Exp Clin Transplant. 2014 Apr; 12(2):95-100.
Score: 0.018